STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
UMC Utrecht
Neonc Technologies, Inc.
Wake Forest University Health Sciences
Sapience Therapeutics
Jonsson Comprehensive Cancer Center
Adela, Inc
NRG Oncology
Mayo Clinic
Harvard Medical School (HMS and HSDM)
Hoffmann-La Roche
M.D. Anderson Cancer Center
University of Southern California
Yale University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
AVM Biotechnology Inc
Maastricht Radiation Oncology
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Centre Leon Berard
Apollomics Inc.
NRG Oncology
Columbia University
Tempus AI
City of Hope Medical Center
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
VitaMed Research LLC
Dana-Farber Cancer Institute
Mayo Clinic
University of Sydney
Peking Union Medical College Hospital
Centre hospitalier de l'Université de Montréal (CHUM)
University of Southern California
University of Virginia
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
University of Florida
Sumitomo Pharma America, Inc.
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Alliance for Clinical Trials in Oncology
Duke University
SpeciCare
Celgene
National Institutes of Health Clinical Center (CC)
Acrotech Biopharma Inc.